Dissecting the Mechanisms of Left Ventricular Diastolic Dysfunction and Inflammation in Peritoneal Dialysis Patients

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wu, Cho Kai ^a,b   Huang, Yin Tsen ^c   Lin, Heng Hsu ^c   Yang, Chung Yi ^b   Lien, Yu Chung ^a   Lee, Jen Kuang ^a,c,d   Huang, Jenq Wen ^a   Hung, Kuan Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAABDOMINAL FAT; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84877679472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062722     Document Type: Article

References (33)

1. Gaasch WH, Zile MR, (2004) Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med. 55: 373-394.
2. Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Mavrou I, et al. (2010) Association of left ventricular diastolic dysfunction with elevated nt-pro-bnp in general intensive care unit patients with preserved ejection fraction: A complementary role of tissue doppler imaging parameters and nt-pro-bnp levels for adverse outcome. Shock 33: 141-148.
3. London GM, (2003) Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. Seminars in Dialysis 16: 85-94.
4. Bajraktari G, Berbatovci-Ukimeraj M, Hajdari A, Ibraimi L, Daullxhiu I, et al. (2009) Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction. Croat Med J 50: 543-549.
5. Stenvinkel P, (2006) Inflammation in end-stage renal disease: The hidden enemy. Nephrology 11: 36-41.
6. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, et al. (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65: 1009-1016.
7. Arici M, Walls J, (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is c-reactive protein the missing link? Kidney Int 59: 407-414.
8. Solerte SB, Fioravanti M, Schifino N, Ferrari E, (1989) Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes 13: 203-211.
9. Lee JK, Lin HH, Tsai CT, Chen JJ, Kuo CC, et al. (2012) Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutr Metab Cardiovasc Dis 22: 974-980.
10. Wu CK, Lee JK, Chiang FT, Yang CH, Huang SW, et al. (2011) Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum ca2+ atpase. Crit Care Med 39: 984-992.
11. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, et al. (2011) Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the vesnarinone trial (vest). Circulation 103: 2055-2059.
12. Saiki A, Nagayama D, Ohhira M, Endoh K, Ohtsuka M, et al. (2005) Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes (Lond) 29: 1115-1120.
13. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, et al. (2008) Unlocking the mysteries of diastolic function: Deciphering the rosetta stone 10 years later. J Am Coll Cardiol 51: 679-689.
14. Wu CK, Luo JL, Wu XM, Tsai CT, Lin JW, et al. (2009) A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. Atherosclerosis 205: 497-502.
15. Wu CK, Tsai CT, Hwang JJ, Luo JL, Juang JM, et al. (2008) Renin-angiotensin system gene polymorphisms and diastolic heart failure. European Journal of Clinical Investigation 38: 789-797.
16. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, et al. (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10: 165-193.
17. Gniuli D, Castagneto-Gissey G, Iaconelli A, Leccesi L, Mingrone G, (2010) Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects. Int J Obes (Lond) 34: 1726-1732.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A, (1978) Recommendations regarding quantitation in m-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
19. Wu CK, Tsai CT, Chang YC, Luo JL, Wang YC, et al. (2009) Genetic polymorphisms of the angiotensin ii type 1 receptor gene and diastolic heart failure. J Hypertens 27: 502-507.
20. Wu CK, Yang CY, Lin JW, Hsieh HJ, Chiu FC, et al. (2012) The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling. Obesity (Silver Spring) 20: 730-737.
21. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, et al. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
22. Hirota H, Yoshida K, Kishimoto T, Taga T, (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad SciU S A 92: 4862-4866.
23. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C, (2005) The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 183: 308-315.
24. Ogston D, McAndrew GM, (1964) Fibrinolysis in obesity. Lancet 2: 1205-1207.
25. Hillebrand JJ, Langhans W, Geary N, (2010) Validation of computed tomographic estimates of intra-abdominal and subcutaneous adipose tissue in rats and mice. Obesity (Silver Spring) 18: 848-853.
26. Mantuano E, Santi S, Filippi C, Manca-Rizza G, Paoletti S, et al. (2007) Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (lps) stimulated production by isolated human monocytes from chronic kidney disease patients. Biomed Pharmacother 61: 360-365.
27. Paraskevas KI, (2008) Statin therapy in peritoneal dialysis patients: Effects beyond lipid lowering. Int Urol Nephrol 40: 165-170.
28. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, et al. (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407.
29. Prabhu SD, (2004) Cytokine-induced modulation of cardiac function. Circ Res 95: 1140-1153.
30. Bryant D, Becker L, Richardson J, Shelton J, Franco F, et al. (1998) Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97: 1375-1381.
31. Nagueh SF, Stetson SJ, Lakkis NM, Killip D, Perez-Verdia A, et al. (2001) Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation 103: 1844-1850.
32. Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, et al. (2000) Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 36: 208-212.
33. de Mattos AM, Ovidio PP, Jordão AA, da Costa JA, Chiarello PG (2013) Association of Body Fat with Inflammation in Peritoneal Dialysis. Inflammation2013 Jan 16.[Epub ahead of print].